Mahesh Karande
2023
In 2023, Mahesh Karande earned a total compensation of $1.7M as President and Chief Executive Officer at Omega Therapeutics, a 56% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $320,320 |
|---|---|
| Option Awards | $765,340 |
| Salary | $578,667 |
| Other | $11,400 |
| Total | $1,675,727 |
Karande received $765.3K in option awards, accounting for 46% of the total pay in 2023.
Karande also received $320.3K in non-equity incentive plan, $578.7K in salary and $11.4K in other compensation.
Rankings
In 2023, Mahesh Karande's compensation ranked 678th out of 3,006 executives tracked by ExecPay. In other words, Karande earned more than 77.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 678 out of 3,006 | 77th |
Division Manufacturing | 383 out of 1,650 | 77th |
Major group Chemicals And Allied Products | 261 out of 918 | 72nd |
Industry group Drugs | 257 out of 881 | 71st |
Industry Biological Products, Except Diagnostic Substances | 88 out of 213 | 59th |
Source: SEC filing on April 29, 2024.
Karande's colleagues
We found two more compensation records of executives who worked with Mahesh Karande at Omega Therapeutics in 2023.